The Food and Drug Administration (FDA) announced that it had received strong support from the animal health industry on its strategy to phase out the use of antibiotics to promote growth in livestock.

According to FDA, 25 out of 26 animal drug companies have agreed in writing that they will voluntarily participate with FDA’s Guidance 213. 

The companies participating represent 99.95% of the total sales of the products affected by Guidance 213.

FDA announced last December its new policy to phase out the use of medically important antibiotics in food animals for food production purposes and reinforce that the therapeutic uses of these drugs will be implemented under the oversight of a veterinarian.